Sawai H et al. |
Activation of peroxisome proliferator-activated receptor-gamma decreases pancreatic cancer cell invasion through modulation of the plasminogen activator system. |
2006 |
Mol. Cancer Res. |
pmid:16547153
|
Huang H et al. |
Peroxisome proliferator-activated receptor gamma ligands improve the antitumor efficacy of thrombospondin peptide ABT510. |
2004 |
Mol. Cancer Res. |
pmid:15498928
|
Kim YI et al. |
Effects of 15-deoxy-∆¹²,¹â´-prostaglandin Jâ‚‚ on the production of IL-8 and the expression of Toll-like receptor 2 in human primary keratinocytes stimulated with lipopolysaccharide. |
2011 |
Mol. Biol. Rep. |
pmid:20174873
|
Weng Y et al. |
Prostaglandin metabolite induces inhibition of TRPA1 and channel-dependent nociception. |
2012 |
Mol Pain |
pmid:23013719
|
Cruz-Orengo L et al. |
Cutaneous nociception evoked by 15-delta PGJ2 via activation of ion channel TRPA1. |
2008 |
Mol Pain |
pmid:18671867
|
Fain JN et al. |
Regulation of leptin release by troglitazone in human adipose tissue. |
2000 |
Metab. Clin. Exp. |
pmid:11092516
|
Sinha D et al. |
15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene. |
1999 |
Metab. Clin. Exp. |
pmid:10381155
|
Rodrigues WF et al. |
15d-PGJ(2) modulates acute immune responses to Trypanosoma cruzi infection. |
2010 |
Mem. Inst. Oswaldo Cruz |
pmid:20428671
|
Sykes L et al. |
Changes in the Th1:Th2 cytokine bias in pregnancy and the effects of the anti-inflammatory cyclopentenone prostaglandin 15-deoxy-Δ(12,14)-prostaglandin J2. |
2012 |
Mediators Inflamm. |
pmid:22690041
|
Carregaro V et al. |
Therapeutic Treatment of Arthritic Mice with 15-Deoxy Δ12,14-Prostaglandin J2 (15d-PGJ2) Ameliorates Disease through the Suppression of Th17 Cells and the Induction of CD4+CD25-FOXP3+ Cells. |
2016 |
Mediators Inflamm. |
pmid:27872515
|
Nozaki Y et al. |
PPARγ ligand attenuates portal inflammation in the MRL-lpr mouse: a new strategy to restrain cholangiopathy in primary biliary cirrhosis. |
2013 |
Med Mol Morphol |
pmid:23397546
|
Kim HJ et al. |
ROSics: chemistry and proteomics of cysteine modifications in redox biology. |
2015 Mar-Apr |
Mass Spectrom Rev |
pmid:24916017
|
Date M et al. |
15-Deoxy-delta12,14-prostaglandin J2, a ligand for peroxisome proliferators-activated receptor-gamma, induces apoptosis in human hepatoma cells. |
2003 |
Liver Int. |
pmid:14986820
|
Gressner OA et al. |
Elevated concentrations of 15-deoxy-Delta12,14-prostaglandin J2 in chronic liver disease propose therapeutic trials with peroxisome proliferator activated receptor gamma-inducing drugs. |
2009 |
Liver Int. |
pmid:19018984
|
Kang MA et al. |
Up-regulation of skeletal muscle LIM protein 1 gene by 25-hydroxycholesterol may mediate morphological changes of rat aortic smooth muscle cells. |
2007 |
Life Sci. |
pmid:17161435
|
Wung BS et al. |
15-Deoxy-Delta(12,14)-prostaglandin J(2) suppresses IL-6-induced STAT3 phosphorylation via electrophilic reactivity in endothelial cells. |
2006 |
Life Sci. |
pmid:16413037
|
Shirahase H et al. |
Inhibitory effects of PGD2, PGJ2 and 15-deoxy-delta12,14-PGJ2 on iNOS induction in rat mesenteric artery. |
2000 |
Life Sci. |
pmid:10834301
|
Liu JD et al. |
Thiol antioxidant and thiol-reducing agents attenuate 15-deoxy-delta 12,14-prostaglandin J2-induced heme oxygenase-1 expression. |
2004 |
Life Sci. |
pmid:14998722
|
Stebulis JA et al. |
Ajulemic acid, a synthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells. |
2008 |
Life Sci. |
pmid:18840450
|
Clemente-Napimoga JT et al. |
15d-PGJ2-loaded in nanocapsules enhance the antinociceptive properties into rat temporomandibular hypernociception. |
2012 |
Life Sci. |
pmid:22564409
|
Jung WK et al. |
The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1. |
2009 |
Life Sci. |
pmid:19409914
|
Kattamuri PV et al. |
Asymmetric synthesis of novel N-(1-phenyl-2,3-dihydroxypropyl)arachidonylamides and evaluation of their anti-inflammatory activity. |
2013 |
Life Sci. |
pmid:22820546
|
Hayden RE et al. |
Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dDelta12,14,PGJ2. |
2009 |
Leukemia |
pmid:18923439
|
Zang C et al. |
Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia. |
2004 |
Leuk. Res. |
pmid:15109539
|
Okano H et al. |
15-deoxy-delta-12-14-PGJ2 regulates apoptosis induction and nuclear factor-kappaB activation via a peroxisome proliferator-activated receptor-gamma-independent mechanism in hepatocellular carcinoma. |
2003 |
Lab. Invest. |
pmid:14563954
|
Chung YW et al. |
[Effects of peroxisome proliferator-activated receptor-gamma agonist on Fas-mediated apoptosis in HT-29 cells]. |
2003 |
Korean J Gastroenterol |
pmid:14532729
|
Rovin BH et al. |
15-Deoxy-Delta12,14-prostaglandin J2 regulates mesangial cell proliferation and death. |
2002 |
Kidney Int. |
pmid:11918736
|
Sawano H et al. |
15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells. |
2002 |
Kidney Int. |
pmid:12028436
|
Stahlschmidt J et al. |
Urothelial differentiation in chronically urine-deprived bladders of patients with end-stage renal disease. |
2005 |
Kidney Int. |
pmid:16105033
|
Zhang X et al. |
Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in human mesangial cells. |
2004 |
Kidney Int. |
pmid:14871400
|
Ueta M et al. |
PPARgamma ligands attenuate mesangial contractile dysfunction in high glucose. |
2004 |
Kidney Int. |
pmid:14871416
|
Chana RS et al. |
Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists. |
2004 |
Kidney Int. |
pmid:15149321
|
Calabrò P et al. |
Inhibition of tumor-necrosis-factor-alpha induced endothelial cell activation by a new class of PPAR-gamma agonists. An in vitro study showing receptor-independent effects. |
2005 Nov-Dec |
J. Vasc. Res. |
pmid:16155367
|
Hong JT et al. |
Inhibitory effect of peroxisome proliferator-activated receptor gamma agonist on ochratoxin A-induced cytotoxicity and activation of transcription factors in cultured rat embryonic midbrain cells. |
2002 |
J. Toxicol. Environ. Health Part A |
pmid:11936221
|
Moraes LA et al. |
Non-genomic effects of PPARgamma ligands: inhibition of GPVI-stimulated platelet activation. |
2010 |
J. Thromb. Haemost. |
pmid:20040043
|
O'Brien JJ et al. |
15-deoxy-Delta12,14 prostaglandin J2-induced heme oxygenase-1 in megakaryocytes regulates thrombopoiesis. |
2009 |
J. Thromb. Haemost. |
pmid:18983509
|
Byrns MC et al. |
Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer. |
2010 |
J. Steroid Biochem. Mol. Biol. |
pmid:20036328
|
Davidson J et al. |
7beta-hydroxy-epiandrosterone modulation of 15-deoxy-delta12,14-prostaglandin J2, prostaglandin D2 and prostaglandin E2 production from human mononuclear cells. |
2008 |
J. Steroid Biochem. Mol. Biol. |
pmid:18996481
|
Andrews WJ et al. |
Aromatase inhibition by 15-deoxy-prostaglandin J(2) (15-dPGJ(2)) and N-(4-hydroxyphenyl)-retinamide (4HPR) is associated with enhanced ceramide production. |
2005 |
J. Steroid Biochem. Mol. Biol. |
pmid:15862961
|
Li X et al. |
Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes. |
2005 |
J. Rheumatol. |
pmid:15868626
|
Viergutz T et al. |
Relationship between different stages of the corpus luteum and the expression of the peroxisome proliferator-activated receptor gamma protein in bovine large lutein cells. |
2000 |
J. Reprod. Fertil. |
pmid:10793637
|
Cha B et al. |
15-deoxy-D12,14-prostaglandin J2 suppresses RANTES expression by inhibiting NADPH oxidase activation in Helicobacter pylori-infected gastric epithelial cells. |
2011 |
J. Physiol. Pharmacol. |
pmid:21673364
|
Korolczuk A et al. |
The role of peroxisome-proliferator-activating receptor gamma agonists: rosiglitazone and 15-deoxy-delta12,14-prostaglandin J2 in chronic experimental cyclosporine A-induced nephrotoxicity. |
2014 |
J. Physiol. Pharmacol. |
pmid:25554991
|
Abdo H et al. |
The omega-6 fatty acid derivative 15-deoxy-Δ¹²,¹â´-prostaglandin J2 is involved in neuroprotection by enteric glial cells against oxidative stress. |
2012 |
J. Physiol. (Lond.) |
pmid:22473776
|
Bach-Ngohou K et al. |
Enteric glia modulate epithelial cell proliferation and differentiation through 15-deoxy-12,14-prostaglandin J2. |
2010 |
J. Physiol. (Lond.) |
pmid:20478974
|
Hatanaka M et al. |
15d-prostaglandin J2 enhancement of nerve growth factor-induced neurite outgrowth is blocked by the chemoattractant receptor- homologous molecule expressed on T-helper type 2 cells (CRTH2) antagonist CAY10471 in PC12 cells. |
2010 |
J. Pharmacol. Sci. |
pmid:20424389
|
Azuma Y et al. |
Possible involvement of p38 in mechanisms underlying acceleration of proliferation by 15-deoxy-Delta(12,14)-prostaglandin J2 and the precursors in leukemia cell line THP-1. |
2004 |
J. Pharmacol. Sci. |
pmid:15037811
|
Takata K et al. |
Possible involvement of small oligomers of amyloid-beta peptides in 15-deoxy-delta 12,14 prostaglandin J2-sensitive microglial activation. |
2003 |
J. Pharmacol. Sci. |
pmid:12719662
|
Kim EJ et al. |
Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway. |
2003 |
J. Pharmacol. Exp. Ther. |
pmid:12966153
|
Shimomura K et al. |
Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion. |
2004 |
J. Pharmacol. Exp. Ther. |
pmid:15201343
|